227 related articles for article (PubMed ID: 1991638)
21. The Importance of Intestinal Eotaxin-1 in Inflammatory Bowel Disease: New Insights and Possible Therapeutic Implications.
Adar T; Shteingart S; Ben-Ya'acov A; Shitrit AB; Livovsky DM; Shmorak S; Mahamid M; Melamud B; Vernea F; Goldin E
Dig Dis Sci; 2016 Jul; 61(7):1915-24. PubMed ID: 26874691
[TBL] [Abstract][Full Text] [Related]
22. Decreased colonic peptide histidine-methionine in idiopathic inflammatory bowel diseases.
Koch TR; Michener SR; Carney JA; Go VL
Dig Dis Sci; 1988 Apr; 33(4):423-8. PubMed ID: 3349889
[TBL] [Abstract][Full Text] [Related]
23. ATF4 Deficiency Promotes Intestinal Inflammation in Mice by Reducing Uptake of Glutamine and Expression of Antimicrobial Peptides.
Hu X; Deng J; Yu T; Chen S; Ge Y; Zhou Z; Guo Y; Ying H; Zhai Q; Chen Y; Yuan F; Niu Y; Shu W; Chen H; Ma C; Liu Z; Guo F
Gastroenterology; 2019 Mar; 156(4):1098-1111. PubMed ID: 30452920
[TBL] [Abstract][Full Text] [Related]
24. Intestinal epithelial cells contribute to the enhanced generation of platelet activating factor in ulcerative colitis.
Ferraris L; Karmeli F; Eliakim R; Klein J; Fiocchi C; Rachmilewitz D
Gut; 1993 May; 34(5):665-8. PubMed ID: 8504968
[TBL] [Abstract][Full Text] [Related]
25. Glycosylation and sulphation of colonic mucus glycoproteins in patients with ulcerative colitis and in healthy subjects.
Morita H; Kettlewell MG; Jewell DP; Kent PW
Gut; 1993 Jul; 34(7):926-32. PubMed ID: 8344580
[TBL] [Abstract][Full Text] [Related]
26. Bactericidal/permeability-increasing protein in colonic mucosa in ulcerative colitis.
Haapamäki MM; Häggblom JO; Grönroos JM; Pekkala E; Alanen K; Nevalainen TJ
Hepatogastroenterology; 1999; 46(28):2273-7. PubMed ID: 10521980
[TBL] [Abstract][Full Text] [Related]
27. Colonic glycoproteins in monozygotic twins with inflammatory bowel disease.
Tysk C; Riedesel H; Lindberg E; Panzini B; Podolsky D; Järnerot G
Gastroenterology; 1991 Feb; 100(2):419-23. PubMed ID: 1985038
[TBL] [Abstract][Full Text] [Related]
28. Altered leukotriene B4 metabolism in colonic mucosa with inflammatory bowel disease.
Ikehata A; Hiwatashi N; Kinouchi Y; Yamazaki H; Ito K; Toyota T
Scand J Gastroenterol; 1995 Jan; 30(1):44-9. PubMed ID: 7701249
[TBL] [Abstract][Full Text] [Related]
29. Prostanoid synthesis by cultured intestinal epithelial and mononuclear cells in inflammatory bowel disease.
Zifroni A; Treves AJ; Sachar DB; Rachmilewitz D
Gut; 1983 Jul; 24(7):659-64. PubMed ID: 6345283
[TBL] [Abstract][Full Text] [Related]
30. Altered lectin binding by colonic epithelial glycoconjugates in ulcerative colitis and Crohn's disease.
Rhodes JM; Black RR; Savage A
Dig Dis Sci; 1988 Nov; 33(11):1359-63. PubMed ID: 3180971
[TBL] [Abstract][Full Text] [Related]
31. Composition of human colonic mucin. Selective alteration in inflammatory bowel disease.
Podolsky DK; Isselbacher KJ
J Clin Invest; 1983 Jul; 72(1):142-53. PubMed ID: 6192143
[TBL] [Abstract][Full Text] [Related]
32. Increased production of vascular endothelial growth factor by intestinal mucosa of patients with inflammatory bowel disease.
Griga T; Voigt E; Gretzer B; Brasch F; May B
Hepatogastroenterology; 1999; 46(26):920-3. PubMed ID: 10370639
[TBL] [Abstract][Full Text] [Related]
33. Electrolyte transport across colonic mucosa from patients with inflammatory bowel disease.
Hawker PC; McKay JS; Turnberg LA
Gastroenterology; 1980 Sep; 79(3):508-11. PubMed ID: 7429111
[TBL] [Abstract][Full Text] [Related]
34. Increased group II phospholipase A2 in colonic mucosa of patients with Crohn's disease and ulcerative colitis.
Minami T; Tojo H; Shinomura Y; Matsuzawa Y; Okamoto M
Gut; 1994 Nov; 35(11):1593-8. PubMed ID: 7828979
[TBL] [Abstract][Full Text] [Related]
35. Platelet interaction with lymphatics aggravates intestinal inflammation by suppressing lymphangiogenesis.
Sato H; Higashiyama M; Hozumi H; Sato S; Furuhashi H; Takajo T; Maruta K; Yasutake Y; Narimatsu K; Yoshikawa K; Kurihara C; Okada Y; Watanabe C; Komoto S; Tomita K; Nagao S; Miura S; Hokari R
Am J Physiol Gastrointest Liver Physiol; 2016 Aug; 311(2):G276-85. PubMed ID: 27313177
[TBL] [Abstract][Full Text] [Related]
36. Alterations in the immunohistochemical expression of Das-1 and CG-3 in colonic mucosal biopsy specimens helps distinguish ulcerative colitis from Crohn disease and from other forms of colitis.
Yantiss RK; Das KM; Farraye FA; Odze RD
Am J Surg Pathol; 2008 Jun; 32(6):844-50. PubMed ID: 18408596
[TBL] [Abstract][Full Text] [Related]
37. Correlations between colonic crypt mucin chemotype, inflammatory grade and Desulfovibrio species in ulcerative colitis.
Lennon G; Balfe Á; Bambury N; Lavelle A; Maguire A; Docherty NG; Coffey JC; Winter DC; Sheahan K; O'Connell PR
Colorectal Dis; 2014 May; 16(5):O161-9. PubMed ID: 24345279
[TBL] [Abstract][Full Text] [Related]
38. Kinetic studies on colonocyte metabolism of short chain fatty acids and glucose in ulcerative colitis.
Clausen MR; Mortensen PB
Gut; 1995 Nov; 37(5):684-9. PubMed ID: 8549946
[TBL] [Abstract][Full Text] [Related]
39. Influence of inflammatory bowel disease on the distribution and concentration of pancreatic secretory trypsin inhibitor within the colon.
Playford RJ; Hanby AM; Patel K; Calam J
Am J Pathol; 1995 Feb; 146(2):310-6. PubMed ID: 7856742
[TBL] [Abstract][Full Text] [Related]
40. A study of histochemical changes in mucus from patients with ulcerative colitis, Crohn's disease, and diverticular disease of the colon.
Habib NA; Dawson PM; Krausz T; Blount MA; Kersten D; Wood CB
Dis Colon Rectum; 1986 Jan; 29(1):15-7. PubMed ID: 3940799
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
